ZTS

硕腾
NYSE

实时行情|Nasdaq Last Sale

117.69
+1.01
+0.87%
盘前: 113.01 -4.68 -3.98% 08:00 04/01 EDT
开盘
115.68
昨收
116.68
最高
120.25
最低
113.90
成交量
395.61万
成交额
--
52周最高
146.26
52周最低
90.14
市值
558.95亿
市盈率(TTM)
37.67
分时
5日
1月
3月
1年
5年

分析师评级

18位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测ZTS价格均价为142.25,最高价位162.00,最低价为112.00。

EPS

ZTS 新闻

更多
  • Cramer's lightning round: Peloton is the 'ultimate stay-at-home stock'
  • CNBC.com · 12小时前
  • Why These 7 Pharma Stocks Are Outplaying 90% Of The Stock Market
  • Investor's Business Daily · 1天前
  • Cramer's lightning round: 'You do want to buy defense stocks right here'
  • CNBC.com · 1天前
  • Cramer's lightning round: 'I like Lockheed Martin very much'
  • CNBC.com · 4天前

所属板块

制药
-0.13%
制药与医学研究
-0.25%

热门股票

代码
价格
涨跌幅

ZTS 简况

Zoetis Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals. The Company's segments include the United States and International. Within each of these operating segments, it offers a product portfolio for both livestock and companion animal customers. Its livestock products include Ceftiofur injectable line, Draxxin, Spectramast, Bovi-Shield line, Rispoval line, Suvaxyn/Fostera, Embrex devices and Lutalyse. Its companion animal products include Clavamox/Synulox, Convenia, ProHeart, Revolution/Stronghold, Apoquel, Cerenia and Rimadyl.
展开

微牛提供Zoetis Inc(NYSE-ZTS)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的ZTS股票新闻,以帮助您做出投资决策。